Trials / Sponsors / Zhongming Qiu
Zhongming Qiu
Academic / Other · 9 registered clinical trials — 9 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM) Inflammatory Myopathy | Phase 2 / Phase 3 | 2026-02-02 |
| Not Yet Recruiting | Ripertamab for the Treatment of Myasthenia Gravis Myasthenia Gravis (MG) | Phase 1 / Phase 2 | 2026-02-01 |
| Not Yet Recruiting | Efgartigimod for the Treatment of Guillain-Barré Syndrome Guillain-Barre Syndrome (GBS) | Phase 2 / Phase 3 | 2025-04-13 |
| Not Yet Recruiting | Ripertamab for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Phase 3 | 2025-03-15 |
| Not Yet Recruiting | Blinatumomab in Refractory Myasthenia Gravis (BLINA-MG) Myasthaenia Gravis | Phase 2 / Phase 3 | 2024-11-30 |
| Not Yet Recruiting | Tirofiban for Successful Endovascular Stroke Thrombectomy Stroke, Acute Ischemic | Phase 2 / Phase 3 | 2024-07-31 |
| Recruiting | Endovascular Treatment for eXtra-Large Ischemic Stroke Stroke, Acute Ischemic | N/A | 2024-06-16 |
| Recruiting | Prospective Registry of Endovascular Thrombectomy for eXtra-Large Ischemic Stroke Acute Ischemic Stroke (AIS), Acute Ischemic Stroke From Large Vessel Occlusion | — | 2024-01-20 |
| Recruiting | DTI-guided Minimally Invasive Hematoma Evacuation for Intracerebral Hemorrhage Stroke Hemorrhagic | N/A | 2023-08-03 |